Hims vs Ro Weight Loss 2026: Cost, Care Model & Verdict
Hims vs Ro weight loss: both offer brand-name GLP-1s, membership billed separately; Compare 2026 costs, billing, medication and a $99/mo annual-plan compounded option.
Quick answer
For weight loss, Hims and Ro both now prescribe FDA-approved brand-name GLP-1s through licensed providers, each billing its membership and medication on its own published terms, so check each provider's current pricing page. Trimi charges $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan (12-month commitment), all-inclusive with free shipping and no membership fee. Compounded medications are not FDA-approved, and results vary by individual.
Written by Trimi Medical Team. Medically reviewed by Dr. Sean Arora, MD. Our team updates competitor reviews when pricing, medication access, pharmacy quality, or provider workflows change so patients can compare GLP-1 options with current context.
Quick links: Semaglutide treatment, tirzepatide treatment, and best GLP-1 provider guide.
More on GLP-1 Provider Comparisons
Hims vs Ro: The Quick Verdict
If you are comparing Hims and Ro for GLP-1 weight loss, you are looking at two of the largest telehealth platforms in the United States, both legitimate, both prescribing real medications through licensed providers. The question is not whether either platform works. In 2026 announcements, both described their weight-loss offerings in terms of FDA-approved brand-name GLP-1s such as Wegovy, while compounded semaglutide, like Trimi's, is prepared per prescription and is not FDA-approved. The question is which platform gives you the best combination of price, support, and flexibility for your specific situation.
Hims and Ro are broad telehealth platforms. Their medication and support options should be checked on their current weight-loss pages. And then there is a third option worth considering: Trimi, which offers compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month on the annual plan, a 12-month commitment, with no membership fee, no consultation fees, and a provider team that focuses exclusively on weight management.
Below, we break down every meaningful comparison point so you can make an informed decision about which platform deserves your investment.
What Is Hims Weight Loss?
Hims, officially Hims & Hers Health (NYSE: HIMS), launched in 2017 as a men's health telehealth platform and has since expanded into one of the largest direct-to-consumer health companies in the country. Their weight loss program gained significant traction through 2024 and 2025. In a March 2026 announcement, Hims said it would no longer advertise compounded GLP-1s; its providers can prescribe FDA-approved brand-name GLP-1s such as Wegovy and Ozempic, and its August 2026 earnings release says compounded access continues on a limited scale.
In March and April 2026 announcements, Hims said its providers can prescribe Wegovy pills, Wegovy injections and Ozempic, and send prescriptions for Zepbound and Foundayo to LillyDirect. Check its current intake and support options.
Hims is a multi-category telehealth platform. In March 2026 it listed a membership billed separately from medication; review the current costs and terms before enrolling.
What Is the Ro Weight Loss Program?
Ro Body is Ro's weight-loss program. Its current pricing page lists ongoing provider support, side effect management and dose adjustments, with membership billed separately from medication.
In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy; check Ro's weight-loss pages for the medications it currently offers. Ro's current pricing page lists ongoing provider support, side effect management and dose adjustments.
Ro bills its membership separately from medication; check Ro's current pricing page or our Ro pricing guide for current costs.
Pricing Comparison: Hims vs Ro vs Trimi
Pricing is typically the first comparison patients make, and for good reason, GLP-1 treatment can last months or years, making even small monthly differences add up to substantial amounts. Here is how the three platforms structure their pricing.
| Feature | Hims | Ro | Trimi |
|---|---|---|---|
| Monthly Price (Semaglutide) | Membership plus separately billed medication; see Hims' pricing page | Membership plus separately billed medication; see Ro's pricing page | $99/mo (annual plan) |
| Monthly Price (Tirzepatide) | Brand-name Zepbound via LillyDirect; see Hims' pricing page | See Ro's current pricing page | $125/mo (annual plan) |
| Consultation Fee | Membership required for medication (March 2026 announcement) | Membership billed separately from medication | Free, always included |
| Contract Required | Membership auto-renews monthly (March 2026 announcement) | Prepaid 3-, 6- and 12-month Wegovy options (March 2026 announcement) | Month-to-month, or annual at a lower monthly rate (12-month term) |
| Shipping Cost | Check Hims' current terms | Check Ro's current terms | Free shipping included |
| Insurance Required | Check Hims' current pages | Cash-pay options available (March 2026 announcement) | No |
Pricing Note
Telehealth pricing changes frequently. In 2026 announcements, Hims and Ro described their weight-loss offerings in terms of FDA-approved brand-name GLP-1s, while Trimi's compounded medications are not FDA-approved. Always verify current pricing directly on each provider's website before making a decision.
Medications Available
In 2026 announcements, Hims said its providers can prescribe Wegovy pills, Wegovy injections and Ozempic, and Ro said cash-pay patients can access the Wegovy pen and Wegovy pill. In the NEJM STEP 1 trial, which studied FDA-approved semaglutide rather than a compounded preparation, semaglutide produced an average weight loss of about 14.9 percent of body weight over 68 weeks, though individual results vary.
Tirzepatide, the dual GIP/GLP-1 receptor agonist, has shown even greater efficacy in clinical trials, up to roughly 21 percent body weight reduction in the NEJM SURMOUNT-1 trial, though individual results vary. That trial also studied the FDA-approved product; compounded preparations are made by state-licensed pharmacies against an individual prescription, are not FDA-approved as drugs, and have not been studied in their own clinical trials. In 2026 announcements, Hims said its providers can send prescriptions for Zepbound vials and Zepbound KwikPen to the LillyDirect pharmacy; for Ro's current tirzepatide options, check Ro's weight-loss pages directly.
Trimi offers both compounded semaglutide and compounded tirzepatide as core offerings. Having both medications reliably available matters because many patients start with semaglutide and later transition to tirzepatide for enhanced results, or vice versa based on tolerability.
Provider Experience Compared
Ask Hims how consultations and ongoing support are delivered, including whether live visits are available for your plan.
Ro's current pricing page lists ongoing provider support, side effect management and dose adjustments. Ask what visit options are available in its current program.
Both Hims and Ro, however, operate broad telehealth platforms that cover many health categories. Trimi's model centers on providers who focus specifically on weight management and metabolic health. Ask how your provider handles GLP-1 dose titration, side effect management, and long-term weight maintenance strategies, and discuss how those services apply to your treatment.
Delivery Speed and Pharmacy Quality
Delivery speed matters when you are eager to start treatment or running low on your current supply. Check each provider's shipping terms before you sign up, since timing includes provider review, prescription processing, pharmacy fulfillment, and shipping.
Trimi ships free overnight once the prescription is compounded, with many patients receiving their first shipment within days of provider approval. Trimi partners with a state-licensed compounding pharmacy, and compounded medications are prepared per individual prescription rather than mass-manufactured, which means they are not FDA-approved as drugs (see the FDA compounding Q&A).
Who Should Choose Hims?
You already use Hims for other health needs and want everything on one platform
You prioritize brand recognition and the reassurance of a publicly traded company
You want a polished app experience for managing your health across multiple categories
Who Should Choose Ro?
You prefer a more clinically comprehensive approach with structured check-ins
You want a platform with established insurance integration for potential brand-name access
Where Trimi Fits
For patients who want compounded GLP-1 treatment with weight-management-focused medical support, Trimi is a third option. Trimi charges $99 per month for compounded semaglutide and $125 per month for compounded tirzepatide on the annual plan, a 12-month commitment, without promo codes; compounded medications are not FDA-approved.
Transparent pricing: $99/mo semaglutide, $125/mo tirzepatide on the annual plan (12-month commitment), no hidden fees
No membership fee, no cancellation fee, and a 6-month money-back policy
Specialized providers: dedicated weight management and metabolic health focus, not generalist telehealth
Fast delivery: free overnight shipping once compounded, on every order
Both medications available: reliable access to both compounded semaglutide and compounded tirzepatide
For a detailed breakdown of all affordable options, see our cheapest legal GLP-1 online cornerstone covering Hims, Ro, Found, Mochi, Henry Meds, LillyDirect with 503A pharmacy compliance citations.
Bottom Line
Hims and Ro are both legitimate telehealth platforms delivering real GLP-1 medications prescribed by licensed providers. Compare their current medication, billing and support options. But for patients who want compounded GLP-1 treatment with dedicated support, Trimi offers a compelling case at $99 per month for semaglutide and $125 per month for tirzepatide on the annual plan, a 12-month commitment, with no membership fee, no hidden fees, and providers who specialize in weight management.
We recommend comparing current pricing directly on each platform before committing. Weight loss treatment is a long-term investment, so compare the full cost over the months you expect to stay on treatment. The best provider is the one that delivers effective medication with quality support at a price you can sustain.
Skip the Hims vs Ro debate
Compounded GLP-1 care with all-inclusive pricing
Trimi's annual plan, a 12-month commitment, is $99/month for clinician-guided compounded semaglutide, or $125/month for compounded tirzepatide, all-inclusive with free shipping and backed by a 6-month money-back policy. Compounded medications are not FDA-approved, every prescription is provider-reviewed, and individual results vary.
Start your online visitFrequently Asked Questions
Is Hims or Ro better for weight loss?
Both Hims and Ro are legitimate telehealth platforms prescribing GLP-1 medications for weight loss. Hims and Ro bill membership separately from medication. Compare their current medication and support options before enrolling. Trimi offers compounded semaglutide, which is not FDA-approved, at $99 per month on the annual plan, a 12-month commitment, with dedicated weight management specialization.
How much does Hims cost vs Ro for semaglutide?
Hims and Ro both bill a membership fee separately from medication, so check each provider's current pricing page. In a March 2026 announcement, Hims said it would no longer advertise compounded GLP-1s. Trimi offers compounded semaglutide at $99 per month on the annual plan, a 12-month commitment, or $175 per month on the month-to-month plan, with no hidden fees. Compounded medications are not FDA-approved.
Do Hims and Ro prescribe the same medications?
In March and April 2026 announcements, Hims said its providers can prescribe Wegovy pills, Wegovy injections and Ozempic, and can send prescriptions for Zepbound and Foundayo to the LillyDirect pharmacy; its August 2026 earnings release says it offers compounded GLP-1 access on a limited scale. In 2026 announcements, Ro described its weight-loss offering in terms of FDA-approved GLP-1 medications such as Wegovy; check Ro's weight-loss pages for the medications it currently offers.
Which platform ships faster, Hims or Ro?
Check each provider's shipping terms, since timing depends on provider review, pharmacy fulfillment and shipping method. Trimi ships free overnight once the prescription is compounded, with many patients receiving their first shipment within days of provider approval.
Can I switch from Hims to Ro or vice versa?
Yes, you can switch between telehealth providers at any time. Before switching, check whether your current plan has any contract obligations or prepaid commitments that would be forfeited. When switching, your new provider will conduct their own clinical evaluation and may adjust your dosing protocol. You do not need to transfer records between platforms, though sharing your medication history is helpful.
Do Hims and Ro require insurance?
Hims and Ro both bill their membership separately from medication. Ro does offer some insurance integration for brand-name medications in certain cases. In March 2026, Hims said separating medication costs from care fees allows for HSA or FSA reimbursement, with eligibility and coverage varying by plan provider. Trimi does not require insurance and offers transparent monthly pricing.
What is an alternative to both Hims and Ro?
Trimi offers compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month on the annual plan, a 12-month commitment, with no consultation fees, no membership fee, and free shipping included. Over a 12-month treatment period, Trimi's annual plan totals $1,188 for semaglutide or $1,500 for tirzepatide, with dedicated weight management support. Hims and Ro bill membership and medication on their own published terms, so check each provider's current pricing page.
Sources & References
- Hims weight loss program information.
- Ro weight loss program information.
- STEP 1 trial: semaglutide in adults with overweight or obesity (PubMed).
- SURMOUNT-1 trial: tirzepatide for obesity (PubMed).
- FDA guidance on compounding and the FDA.
- Wegovy prescribing information from the FDA.
- NIDDK overview of prescription medications for overweight and obesity.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Trimi is a competitor to both Hims and Ro, this comparison aims to be fair and balanced, but readers should be aware of our perspective when evaluating the information presented.